Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

25(R,S)-Ruscogenin

Cat. No.: IBDI-430996

Ruscogenin suppresses HCC metastasis by reducing the expression of MMP-2, MMP-9, uPA, VEGF and HIF-1α via regulating the PI3K/Akt/mTOR signaling pathway. And Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by su

Size (Solid):

Product Details

Target Apoptosis | PI3K | Akt | mTOR
Molecular Weight 430.62
Appearance Solid
SMILES C[[email protected]@]12[[email protected]]3([H])[[email protected]@](C[[email protected]@]1([H])[[email protected]@]4([H])[[email protected]]([[email protected]@]5(C(C[[email protected]](C[[email protected]]5O)O)=CC4)C)([H])CC2)([H])O[[email protected]]6(CCC(CO6)C)[[email protected]]3C
Structure Classification Steroids
Purity 99.84%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.